Seegnal Inc. offers SaaS solutions for clinical decision support, focusing on drug-related patient issues. However, the company faces significant financial concerns, with a gross margin of -4.3% and an alarming EBITDA margin of -192.9%, indicating operational inefficiencies. Additionally, a current ratio of 0.16 suggests liquidity challenges, raising concerns about its ability to meet short-term obligations. While the healthcare sector has growth potential, these financial metrics highlight substantial risks that investors should consider.
Loading financial metrics...
Company has $181K in cash but burned $719K last quarter. At this burn rate, only 0.3 quarters of runway remain without additional financing.
Company posted a loss of $-6.4M over the last year, representing 468.5% of revenue.
Debt of $2.7M is 14.8x the company's cash position of $181K.
Operating cash flow has been negative for 3 consecutive quarters, burning $2.9M over the last year.
Exceptional revenue growth of 123.3% YoY demonstrates strong market demand and competitive positioning.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Health Information Services companies of a similar size
Based on 2026-Q2 (June 30, 2026)